Cargando…
Long-term disease-free survival in surgically-resected oral tongue cancer: a 10-year retrospective study
Early and loco-regionally advanced oral tongue squamous cell carcinoma (OTSCC) can be treated by surgery alone or followed by adjuvant radiotherapy or chemoradiotherapy. Nevertheless, up to 40% of patients develop tumour relapse. The aim of our study is to investigate the clinical and pathological f...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pacini Editore Srl
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522864/ https://www.ncbi.nlm.nih.gov/pubmed/31097825 http://dx.doi.org/10.14639/0392-100X-2336 |
_version_ | 1783419204915953664 |
---|---|
author | MARRA, A. VIOLATI, M. BROGGIO, F. CODECÀ, C. BLASI, M. LUCIANI, A. ZONATO, S. RABBIOSI, D. MONEGHINI, L. SAIBENE, A. MACCARI, A. FELISATI, G. FERRARI, D. |
author_facet | MARRA, A. VIOLATI, M. BROGGIO, F. CODECÀ, C. BLASI, M. LUCIANI, A. ZONATO, S. RABBIOSI, D. MONEGHINI, L. SAIBENE, A. MACCARI, A. FELISATI, G. FERRARI, D. |
author_sort | MARRA, A. |
collection | PubMed |
description | Early and loco-regionally advanced oral tongue squamous cell carcinoma (OTSCC) can be treated by surgery alone or followed by adjuvant radiotherapy or chemoradiotherapy. Nevertheless, up to 40% of patients develop tumour relapse. The aim of our study is to investigate the clinical and pathological features associated with reduced disease-free survival (DFS) in a cohort of surgically-resected OTSCC patients. One hundred and six patients surgically resected for OTSCC were retrospectively identified from clinical records. DFS was calculated according to the Kaplan–Meier method and differences between variables were assessed with Log-Rank test. A multivariable Cox regression model was used to analyse the impact of different prognostic factors on DFS. After a median of follow-up of 8.9 years, 22 events, including 11 deaths, were observed. Overall, the 5-year DFS-rate was 87.4%. The presence of extra-nodal extension (p = 0.023) and perineural invasion (p = 0.003) were significantly correlated with shorter DFS (in univariate analysis). In multivariable analysis, extra-nodal extension and perineural invasion confirmed their role as independent prognostic factors associated with an increased risk of disease recurrence [hazard ratio (HR) 2.87, 95% CI 1.11-7.42, p = 0.03; HR 3.85, 95% CI 1.49-9.96, p = 0.006, respectively]. p16 and p53 expressions in tumour cells were detected in 12% (n = 9) and 46% (n = 40) of cases, respectively. No differences in DFS were observed between p16+ and p16- (p = 0.125) and between p53+ and p53- tumours (p = 0.213). In conclusion, radical surgery, eventually followed by adjuvant radiotherapy or chemo-radiotherapy, can achieve high cure rates in OTSCC. After long-term follow-up, perineural invasion and extra-nodal extension confirmed their role as prognostic factors associated with reduced DFS in OTSCC patients. |
format | Online Article Text |
id | pubmed-6522864 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Pacini Editore Srl |
record_format | MEDLINE/PubMed |
spelling | pubmed-65228642019-05-28 Long-term disease-free survival in surgically-resected oral tongue cancer: a 10-year retrospective study MARRA, A. VIOLATI, M. BROGGIO, F. CODECÀ, C. BLASI, M. LUCIANI, A. ZONATO, S. RABBIOSI, D. MONEGHINI, L. SAIBENE, A. MACCARI, A. FELISATI, G. FERRARI, D. Acta Otorhinolaryngol Ital Head and Neck Early and loco-regionally advanced oral tongue squamous cell carcinoma (OTSCC) can be treated by surgery alone or followed by adjuvant radiotherapy or chemoradiotherapy. Nevertheless, up to 40% of patients develop tumour relapse. The aim of our study is to investigate the clinical and pathological features associated with reduced disease-free survival (DFS) in a cohort of surgically-resected OTSCC patients. One hundred and six patients surgically resected for OTSCC were retrospectively identified from clinical records. DFS was calculated according to the Kaplan–Meier method and differences between variables were assessed with Log-Rank test. A multivariable Cox regression model was used to analyse the impact of different prognostic factors on DFS. After a median of follow-up of 8.9 years, 22 events, including 11 deaths, were observed. Overall, the 5-year DFS-rate was 87.4%. The presence of extra-nodal extension (p = 0.023) and perineural invasion (p = 0.003) were significantly correlated with shorter DFS (in univariate analysis). In multivariable analysis, extra-nodal extension and perineural invasion confirmed their role as independent prognostic factors associated with an increased risk of disease recurrence [hazard ratio (HR) 2.87, 95% CI 1.11-7.42, p = 0.03; HR 3.85, 95% CI 1.49-9.96, p = 0.006, respectively]. p16 and p53 expressions in tumour cells were detected in 12% (n = 9) and 46% (n = 40) of cases, respectively. No differences in DFS were observed between p16+ and p16- (p = 0.125) and between p53+ and p53- tumours (p = 0.213). In conclusion, radical surgery, eventually followed by adjuvant radiotherapy or chemo-radiotherapy, can achieve high cure rates in OTSCC. After long-term follow-up, perineural invasion and extra-nodal extension confirmed their role as prognostic factors associated with reduced DFS in OTSCC patients. Pacini Editore Srl 2019-04 /pmc/articles/PMC6522864/ /pubmed/31097825 http://dx.doi.org/10.14639/0392-100X-2336 Text en Società Italiana di Otorinolaringoiatria e Chirurgia Cervico-Facciale, Rome, Italy http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), which permits for noncommercial use, distribution, and reproduction in any digital medium, provided the original work is properly cited and is not altered in any way. For details, please refer to https://creativecommons.org/licenses/by-nc-nd/4.0/ |
spellingShingle | Head and Neck MARRA, A. VIOLATI, M. BROGGIO, F. CODECÀ, C. BLASI, M. LUCIANI, A. ZONATO, S. RABBIOSI, D. MONEGHINI, L. SAIBENE, A. MACCARI, A. FELISATI, G. FERRARI, D. Long-term disease-free survival in surgically-resected oral tongue cancer: a 10-year retrospective study |
title | Long-term disease-free survival in surgically-resected oral tongue cancer: a 10-year retrospective study |
title_full | Long-term disease-free survival in surgically-resected oral tongue cancer: a 10-year retrospective study |
title_fullStr | Long-term disease-free survival in surgically-resected oral tongue cancer: a 10-year retrospective study |
title_full_unstemmed | Long-term disease-free survival in surgically-resected oral tongue cancer: a 10-year retrospective study |
title_short | Long-term disease-free survival in surgically-resected oral tongue cancer: a 10-year retrospective study |
title_sort | long-term disease-free survival in surgically-resected oral tongue cancer: a 10-year retrospective study |
topic | Head and Neck |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522864/ https://www.ncbi.nlm.nih.gov/pubmed/31097825 http://dx.doi.org/10.14639/0392-100X-2336 |
work_keys_str_mv | AT marraa longtermdiseasefreesurvivalinsurgicallyresectedoraltonguecancera10yearretrospectivestudy AT violatim longtermdiseasefreesurvivalinsurgicallyresectedoraltonguecancera10yearretrospectivestudy AT broggiof longtermdiseasefreesurvivalinsurgicallyresectedoraltonguecancera10yearretrospectivestudy AT codecac longtermdiseasefreesurvivalinsurgicallyresectedoraltonguecancera10yearretrospectivestudy AT blasim longtermdiseasefreesurvivalinsurgicallyresectedoraltonguecancera10yearretrospectivestudy AT luciania longtermdiseasefreesurvivalinsurgicallyresectedoraltonguecancera10yearretrospectivestudy AT zonatos longtermdiseasefreesurvivalinsurgicallyresectedoraltonguecancera10yearretrospectivestudy AT rabbiosid longtermdiseasefreesurvivalinsurgicallyresectedoraltonguecancera10yearretrospectivestudy AT moneghinil longtermdiseasefreesurvivalinsurgicallyresectedoraltonguecancera10yearretrospectivestudy AT saibenea longtermdiseasefreesurvivalinsurgicallyresectedoraltonguecancera10yearretrospectivestudy AT maccaria longtermdiseasefreesurvivalinsurgicallyresectedoraltonguecancera10yearretrospectivestudy AT felisatig longtermdiseasefreesurvivalinsurgicallyresectedoraltonguecancera10yearretrospectivestudy AT ferrarid longtermdiseasefreesurvivalinsurgicallyresectedoraltonguecancera10yearretrospectivestudy |